Monitor blood glucose in patients with type 2 diabetes Acute Kidney Injury: There have been postmarketing reports of acute kidney injury and worsening of chronic renal failure, which in some cases required hemodialysis, in patients treated with semaglutide
Pharmaceutical versions of GLP-1, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), were initially developed to treat type 2 diabetes but are now widely prescribed for weight loss and other health conditions
Both treatment arms were in conjunction with lifestyle intervention
Inject it once a week on the same day, at any convenient time
Once-weekly 2.4mg semaglutide led to a 12.7 kg (~28 lb) weight loss over placebo in the pivotal Phase 3 trial (NCT03548935)
Acid reflux and burping typically peak in the first 24 hours and worsen when lying down